Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
By using our website, you agree to our use of cookies.
Loading your cart..
English 
Chinese
The West Blog
Latest Post
August 14, 2020
How the FDA PFDD initiative is bringing the patients voice earlier into drug development
In the biologics space, there are clear trends toward higher delivery volumes, less frequent dosing, and the conversion from intravenous to subcutaneous delivery. This is driving demand for wearable technologies. Read more below about the FDA’s Patient-Focused Drug Development (PFDD) Initiative and how these findings can enable more insightful patient offerings.
Previous Posts
